SecBot SecBot
SC 13G ·Filed Oct 22, 2026

EDVA

Endovia Health Sciences, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5d 3h ago SEC0000919574-26-007133
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any subsequent amendment converting this 13G to a 13D, which would signal activist intent. For now, the passive filing suggests no near-term management engagement — the 7.2% stake is notable but routine for a hedge fund position.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+1d
EDVA ▼ -1.44% at T+1d
NEUTRAL call -1.44% · α vs SPY -2.15% · entry $0.1600 → $0.1577
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 22, 2026
via day close
T+1d
-1.44%
call -1.44% · α -2.15%
$0.1577
settled 5d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

C/M Capital Partners, LP and related entities filed a Schedule 13G disclosing a passive 7.2% stake in Endovia Health Sciences, Inc., representing 797,592 common shares held by C/M Capital Master Fund, LP as of October 15, 2026. The filing certifies no intent to influence control, making this a routine passive ownership disclosure.

Key Financial Metrics

Stake
7.2%
Investor
C/M Capital Partners, LP
Investor Type
hedge fund

Key Facts

  • C/M Capital Partners, LP and affiliates disclosed a 7.2% beneficial ownership stake in Endovia Health Sciences, Inc.
  • Stake consists of 797,592 shares of common stock held by C/M Capital Master Fund, LP.
  • Filing certifies passive intent under Rule 13d-1(c) — no control or influence purpose.
  • Stake calculated based on 11,079,337 shares outstanding as of October 2, 2026.
  • Reporting persons include C/M Capital Master Fund, LP, C/M Capital Partners, LP, Thomas Walsh, and Jonathan Juchno.

Financial Impact

7.2% passive stake valued at approximately $[undisclosed] based on market price at filing date — no transaction amount disclosed.

ownership concentration

Risk Factors

  • Potential future conversion to 13D if investor decides to engage actively with management.
  • Sell-down by the fund could pressure stock price given the 7.2% position size.

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000919574-26-007133
Document: 0000919574-26-007133-index-headers.html0000919574-26-007133
Document: 0000919574-26-007133-index.html0000919574-26-007133
Document: 0000919574-26-007133.txt0000919574-26-007133
9 reports for EDVA
Performance horizon
80% Hit rate @ T+1 4 of 5 directional calls Went positive at some point 4 of 5 best @ T+20▲ +50.96%Aug 25, 2026
Filters
Rows
Reports for EDVA — sortable, filterable
TypeNow
Oct 27, 2026
today
S-1
BEARISH ★ 5/10
$0.1613awaiting T+1—$0.1580 (+2.05%)
Oct 27, 2026
today
8-K
BEARISH ★ 6/10
$0.1651awaiting T+1—$0.1580 (+4.30%)
Oct 22, 2026
5d ago
SC 13G
NEUTRAL ★ 4/10
$0.1600 $0.1577▼ −1.44%▼ −2.15%$0.1580 (−1.25%)
Oct 15, 2026
12d ago
8-K
BEARISH ★ 5/10
$0.1460 $0.1350▲ +7.53%▲ +7.96%$0.1580 (−8.22%)
Oct 6, 2026
21d ago
8-K
BEARISH ★ 6/10
$0.1650 $0.1599▲ +3.09%▲ +2.67%$0.1580 (+4.24%)
Oct 5, 2026
22d ago
DEF 14A
BEARISH ★ 7/10
$0.1679 $0.1650▲ +1.73%▲ +1.49%$0.1580 (+5.90%)
Oct 5, 2026
22d ago
8-K
BULLISH ★ 6/10
$0.1680 $0.1650▼ −1.79%▼ −1.55%$0.1580 (−5.95%)
Aug 31, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$0.2954 $0.2614▼ −11.51%▼ −11.95%$0.1580 (−46.51%)
Aug 25, 2026
9w ago
EFFECT
BEARISH ★ 6/10
$0.4182 $0.3650▲ +12.72%▲ +12.74%$0.1580 (+62.22%)
Showing 9 of 9

US Market Status

Market Closed — Opens Thu (12h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 22, 2026